Company / FCF Margin
Fulgent Genetics, Inc. FCF Margin History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest FCF Margin
-38.5%
FY2025
5-year range
-38.5% / 51.9%
FY2021-FY2025
Trend
-466.9%
vs FY2024
Sector context
#136 of 145
Health Care
What the data says
FCF Margin changed -467% YoY in FY2025, a notable deviation from the 9-year average annual change of -6%.
Based on SEC 10-K filings.
-38.5% in FY2025 with a 5-year CAGR of -63.5%.
Declined from 51.9% to -38.5% over the past 2 years.
Health Care sector context is included.
FCF Margin over time
Growth rates
- 3-Year Change
- -63.5pp
- 5-Year Change
- -63.5pp
- 10-Year Change
- -
Sector benchmark
Bottom 6% in Health CareTop 94% of 145This company -38.5% Sector average -207.5%
▼
+81.5% above sector average
Key checks
Key Insights
- In FY2025, fcf margin decreased 466.9% year-over-year.
- Currently 169.0pp above the Health Care sector average.
- Peak fcf margin was recorded in FY2023.
- Lowest fcf margin in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 5.28 (safe zone, above 2.9 threshold)
- Negative profit margin: -15.1%
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | FCF MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -38.5% | -466.9% |
| FY2024 | -6.8% | -113.1% |
| FY2023 | 51.9% | +107.3% |
| FY2022 | 25.0% | +87.7% |
| FY2021 | 13.3% | -46.7% |
| FY2020 | 25.0% | +278.2% |
| FY2019 | -14.0% | -68.1% |
| FY2018 | -8.3% | +71.7% |
| FY2017 | -29.5% | +92.7% |
| FY2016 | -401.3% | -1152.0% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026